Revaprazan Hydrochloride CAS 178307-42-1 Intende ≥99.0% API Factory High Purity Featured Image

Revaprazan Hydrochloride CAS 178307-42-1 Intende ≥99.0% API Factory High Munditia

Description:

Name: Revaprazan hydrochloride;Revaprazan HCL

CAS: 178307-42-1

Aspectus: Alba vel Off-White Crystalline pulveris

Dic: ≥99.0%

Acidum obstructores potassium-competitivi (P-CAB), in curatione ulceris duodeni, ulceris gastrici et gastritis.

API High Quality, Commercial Production

E-mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Chemical Name: Revaprazan Hydrochloridum;Revaprazan HCL
CAS: 178307-42-1
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Revaprazan hydrochloride
Synonyma	Revaprazan HCL
CAS Number	178307-42-1
CATTUS Number	RF-API48
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C22H24ClFN4
M. Pondus	398.904
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba vel Off-White Crystalline pulveris
Solubilitas	Dichlormeth chloroformi libere solutum;Solutum in acido acetico;Leviter solutum in methanolum, DMSO;Vix solutum in acetone, ACN;Fere non solutum in solutione 0.1mol/L NaOH.0.1mol/L HCL solutio.
Lepidium sativum	Si prorsus responderit λ max 271nm 205nm IR
Liquescens punctum	219.0~222.0℃
Claritas et Color	Patet et hyalina in dichlormeth
Chloride	≤8.93%
una immunditia	≤0.10%
Totalis immunditias	≤0.50%
Damnum in Siccatio	≤0.50%
Residere in Ignition	≤0.10%
Sulfate	≤20ppm
Arsenicum	≤10ppm
Metalla gravis	≤10ppm
Assay	≥99.0%
Test Standard	Enterprise Standard
Consuetudinem	Active Pharmaceutical Ingredient (API)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum Hydrochloridis Revaprazan (CAS: 178307-42-1) cum qualitate magna.Revaprazan hydrochloride COX-2 expressionem minuit et actiones inflammatoriae in H. pylori infectio significantes habet.Revaprazan de hydrochloride in curatione ulceris duodeni, ulceris gastrici et gastritis.
Revaprazan hydrochloride (etiam nota convertitur inhibitores sentinae protónis, potassium acidi competitive obstructores, p-CABs) est nova generatio convertibilis inhibitores sentinarum protonatorum et solum commercium available potassium sentinam inhibitores acidi auctoriales vel antagonistae in mundo.Developed by South Corean company Yuhan et cum iure proprietatis intellectualis proprietatis, GLAxoSmithKline terrarum evolutionem et licentias venalium medicamentorum extra Coream Septentrionalem et Coream Septentrionalem adeptus est.Medicamentum probatum est a FDA Coreana Australi 2007 ut ulcera duodena et gastritis tractaret.